S 2469, the Strategies to Address Antibiotic Resistance (STAAR) Act, addresses the growing problem of antibiotic resistance by amending the Public Health Service Act to require the Antimicrobial Resistance Task Force to consider the outcomes from the National Action Plan for Combating Antibiotic-Resistance Bacteria (“Action Plan”) in its recommendations to the government. By increasing available funds for this task force, the bill requires public meetings and reports; it likewise emphasizes collaboration, data analysis, and innovative research for prevention and treatment of antibiotic resistant infections.
Further, S 2469 would require the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria to make recommendations to the federal government regarding programs and policies relating to antibiotic resistance, including those related to the Action Plan and the National Strategy for Combating Antibiotic-Resistant Bacteria. Additionally, the Centers for Disease Control and Protection would use the National Healthcare Safety Network to assess appropriate conditions, outcomes, and measures related to antibacterial resistance; the CDC would also create at least seven laboratories focused on antibiotic resistance surveillance. Finally, the bill requires the CDC to maintain and analyze the Clinical Trials Network on Antibacterial Resistance, and to expand collaborative efforts with states and local health departments to prevent the spread of antibiotic resistant bacteria.